Close Menu

NEW YORK – Invitae is selling $300 million in convertible senior notes in a private offering. 

The company increased the offering size from the previously announced $200 million and granted initial purchasers of the notes a 13-day option to purchase an additional $50 million worth of notes under the same terms and conditions. Invitae is expecting net proceeds of $291.2 million or $339.8 million if purchasers exercise the option to buy additional notes. 

The sale is slated to close on Sept. 10. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.